About
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
Current Value
$195.461 Year Return
Current Value
$195.461 Year Return
Key Details
Market Cap
$141.59B
P/E Ratio
37.43
1Y Stock Return
-18.19%
1Y Revenue Growth
-13.50%
Dividend Yield
0.47%
Price to Book
2.9
Strategies that include DHR
Double maintains 11 strategies that include DHR - Danaher Corp.
US Top 500
Medium risk
$14.0K
The textbook passive investment vehicle is generally considered to comprise of 500 of the largest stocks traded within the US. Double's take on this exposes a client to the US stock market in a diversified way without any expense ratio.
Top Sector
Information Technology
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
502
Value Stocks
Medium risk
$6.8K
This Strategy targets undervalued stocks in the U.S. market, emphasizing companies with solid fundamentals and potential for long-term growth. Emphasizing sectors such as healthcare, financials, industrials, and consumer goods, it seeks opportunities where market prices may not fully reflect underlying value metrics like earnings and book value.
Top Sector
Financials
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
337
Health Care Sector
Medium risk
$14.0K
This Strategy focuses on healthcare companies, including pharmaceuticals, biotechnology, healthcare providers, and medical equipment firms. Offering exposure to a sector driven by demographic trends and ongoing medical advancements, it's a strategic choice for investors considering healthcare's long-term growth potential.
Top Sector
Health Care
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
346
Equal Weighted US Top 500
Medium risk
$3.1K
This index provides equal-weight exposure to the top 500 companies in the US, offering a unique approach compared to traditional market-cap weighted indexes. With an aim to reduce concentration risk by allocating equal amounts to each constituent, it potentially benefits from smaller companies' outperformance.
Top Sector
Industrials
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
502
US 1000
Medium risk
$33.0K
This strategy tracks a market-cap-weighted index of the 1000-largest US companies. It offers broad exposure to the US equity market, encompassing a diverse range of sectors and industries. By investing in this fund, you gain access to the performance of large and well-established companies within the US economy.
Top Sector
Information Technology
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
1000
Stock's related to DHR
The stocks that are correlated to DHR - Danaher Corp. are TMO, RGEN, A, BIO, RVTY
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| 69.56% | $177.32B | -17.63% | 0.35% | |
R RGENRepligen Corp. | 60.95% | $6.83B | -29.63% | 0.00% |
| 59.52% | $31.27B | -22.41% | 0.92% | |
| 52.89% | $6.58B | -27.28% | 0.00% | |
R RVTYRevvity, Inc. | 51.80% | $12.10B | -0.91% | 0.29% |
A AVTRAvantor, Inc. | 51.63% | $10.67B | -37.57% | 0.00% |
Q QGENQIAGEN NV | 51.30% | $8.79B | -4.53% | 0.00% |
A ASHAshland, Inc. | 49.97% | $2.50B | -44.33% | 3.19% |
T TECHBio-Techne Corp. | 49.66% | $8.67B | -18.18% | 0.61% |
B BRKRBruker Corp. | 48.62% | $5.71B | -58.05% | 0.56% |
| 48.48% | $22.83B | -14.74% | 0.00% | |
| 48.31% | $9.89B | -33.17% | 0.00% | |
W WATWaters Corp. | 47.37% | $20.50B | +3.25% | 0.00% |
M MHOM/I Homes, Inc. | 47.29% | $2.96B | -12.16% | 0.00% |
| 46.79% | $29.57B | -29.70% | 0.00% | |
Q QDELQuidelOrtho Corp. | 45.74% | $2.19B | -23.88% | 0.00% |
| 45.28% | $1.93B | -28.19% | 1.75% | |
| 43.46% | $4.78B | -17.78% | 4.09% | |
| 43.46% | $22.29B | -7.59% | 2.55% | |
J JOEThe St. Joe Co. | 43.40% | $2.63B | -19.91% | 1.23% |
ETF's related to DHR
The ETFs that are correlated to DHR - Danaher Corp. are RSPH, FHLC, VHT, FBT, MOAT
Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| 56.91% | $790.48M | 0.4% | |
| 54.79% | $2.68B | 0.084% | |
| 54.70% | $16.30B | 0.09% | |
| 53.54% | $1.09B | 0.56% | |
| 53.32% | $13.48B | 0.47% | |
| 53.04% | $3.17B | 0.39% | |
| 52.23% | $5.70B | 0.45% | |
| 52.09% | $3.91B | 0.41% | |
| 51.99% | $48.65M | 0.69% | |
| 51.82% | $37.96B | 0.09% | |
| 51.21% | $964.24M | 0.62% | |
| 50.09% | $362.92M | 0.35% | |
| 49.95% | $1.74B | 0.53% | |
| 49.60% | $48.48M | 0.5% | |
| 49.33% | $2.09B | 0.59% | |
| 47.38% | $229.13M | 0.58% | |
| 47.10% | $141.74M | 0.5% | |
| 46.89% | $1.40B | 0.35% | |
| 46.67% | $422.06M | 0.49% | |
| 46.35% | $176.51M | 0.35% | |
News
Yahoo
DHR is poised to gain from strength in the clinical diagnostics business, the Abcam buyout and shareholder-friendly policies. Softness in Life Sciences and Biotechnology units remains a concern.
SeekingAlpha
For Q1 2025, Andvari is up 7.2% net of fees while the SPDR S&P 500 ETF (SPY) is down 4.3%. Click here to read the full letter.
MarketWatch
Danaher Corp. stock outperforms competitors despite losses on the day
Yahoo
Artisan Partners, an investment management company, released its “Artisan Global Opportunities Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. US equities experienced significant gains in Q4, showcasing a strong year. The portfolio showed slight weakness in Q4 but posted a strong absolute return in 2024. In the fourth […]
MarketWatch
Danaher Corp. stock outperforms competitors on strong trading day
SeekingAlpha
3 Wide-Moat Dividend Stars For A Championship Portfolio
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
0% Expense Ratios with TLH
We offer over 50 indexes with zero expense ratios.
Registration will take about 10 seconds